Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 May;50(5):518-523.
doi: 10.1055/s-0043-123577. Epub 2017 Dec 18.

Motorized spiral colonoscopy: a first single-center feasibility trial

Affiliations
Clinical Trial

Motorized spiral colonoscopy: a first single-center feasibility trial

Torsten Beyna et al. Endoscopy. 2018 May.

Abstract

Background: Cecal intubation rate represents a key procedural quality parameter in diagnostic colonoscopy. However, even experienced investigators report 10 % of all colonoscopies to be difficult and intubation of the cecum is sometimes impossible. A recently developed novel motorized spiral endoscope might potentially overcome some limitations of standard colonoscopy by actively pleating the bowel onto the endoscope. The study aim was to evaluate the feasibility and safety of motorized spiral colonoscopy (MSC) for diagnostic colonoscopy.

Methods: 30 consecutive patients with an indication for diagnostic colonoscopy were enrolled in a proof-of-concept single-center trial.

Results: 13 men and 17 women (mean age 68.9 years, range 30 - 90) were enrolled; 43.3 % had diverticula. Mean procedure time was 20.8 min (range 11.4 - 55.3). Cecal intubation rate was 96.7 %. One incomplete colonoscopy occurred because of an unexpected postinflammatory stricture. Adenoma detection rate was 46.6 %. No severe adverse events occurred.

Conclusions: Results indicate that MSC is safe and effective for diagnostic colonoscopy. It potentially offers advantages in terms of ease and it may facilitate therapeutic interventions.

Trial registration: ClinicalTrials.gov NCT03000361.

PubMed Disclaimer

Conflict of interest statement

Authors H. Neuhaus and T. Beyna received consultancy honoraria from Olympus Medical Systems Corporation. Authors M. Schneider, J. Kandler, D. Pullman, and C. Gerges have no competing interests.

Comment in

Publication types

Associated data